(NIH/National Institute of General Medical Sciences) NIH plans to spend $161.3 million over the next five years to expand the nationwide Pharmacogenomics Research Network. Since its launch in 2000, the network has studied how genes affect individual responses to medicines for heart disease, asthma, various cancers, nicotine addiction and other conditions. In addition to these areas, the expanded network will focus on rheumatoid arthritis, bipolar disorder and the use of pharmacogenetics in rural and underserved populations.
Read »- Anonymous
Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Medicine
- NKT Cells Stimulated by Long Fatty Acyl Chain Sulfatides Significantly Reduces the Incidence of Type 1 Diabetes in Nonobese Diab
- Psychological Science explains uproar over prostate-cancer screenings
- IL28B Genetic Variation Is Associated with Spontaneous Clearance of Hepatitis C Virus, Treatment Response, Serum IL-28B Levels i
- New process would make anti-malarial drug less costly
- Mayo Clinic Alzheimer's researcher honored twice in a month